A detailed history of Sherbrooke Park Advisers LLC transactions in Dexcom Inc stock. As of the latest transaction made, Sherbrooke Park Advisers LLC holds 11,100 shares of DXCM stock, worth $890,664. This represents 0.17% of its overall portfolio holdings.

Number of Shares
11,100
Previous 7,488 48.24%
Holding current value
$890,664
Previous $849 Million 12.35%
% of portfolio
0.17%
Previous 0.15%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$64.0 - $116.06 $231,168 - $419,208
3,612 Added 48.24%
11,100 $744 Million
Q2 2024

Aug 14, 2024

BUY
$110.31 - $140.45 $440,026 - $560,255
3,989 Added 114.0%
7,488 $849 Million
Q1 2024

May 15, 2024

BUY
$114.22 - $140.1 $399,655 - $490,209
3,499 New
3,499 $485 Million
Q3 2023

Nov 14, 2023

BUY
$86.06 - $137.93 $1 Million - $1.61 Million
11,648 New
11,648 $1.09 Billion
Q1 2023

May 15, 2023

BUY
$104.0 - $122.92 $228,800 - $270,424
2,200 New
2,200 $256 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Sherbrooke Park Advisers LLC Portfolio

Follow Sherbrooke Park Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sherbrooke Park Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sherbrooke Park Advisers LLC with notifications on news.